RxDoctor Payments Data

Kent Willyard, MD

Family Medicine · Newport News, VANPI 1023009214

Payments from drug & device makers

$4,670in general payments, 2019–2025

Across 280 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$731
  • AbbVie$521
  • GSK$508
  • Novo Nordisk$479
  • Pfizer$347
  • Amgen$207
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$4,62899%
  • Education$421%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,670 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$186,812
Medicare patients
290
Services billed
4,392

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol31$39,787
EliquisApixaban21$23,467
JardianceEmpagliflozin11$15,196
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp11$4,811
Atorvastatin Calcium387$2,810
Ezetimibe87$2,539
Brimonidine Tartrate20$2,296
Amlodipine-ValsartanAmlodipine Besylate/Valsartan14$2,241
Metoprolol Succinate99$1,475
Rosuvastatin Calcium110$1,405
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide124$1,369
SynthroidLevothyroxine Sodium30$1,330
Losartan Potassium144$1,223
Tamsulosin Hcl80$1,160
Omeprazole111$1,032

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$731$39,78731 claims
PfizerEliquis$347$23,46721 claims
Boehringer IngelheimJardiance$172$15,19611 claims
AbbVieSynthroid$521$1,33030 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →